Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Neuromuscul Disord. 2010 Jul 13;20(8):499–504. doi: 10.1016/j.nmd.2010.05.010

Figure.

Figure

Representative fields from clinical muscle biopsy (from 2002) of the quadriceps muscle in a DMD manifesting carrier with 100% skewing of X chromosome inactivation (subject #8), and a control skeletal muscle. Immunohistochemical staining was performed under a clinical protocol using as a primary antibody Mab1645 (Chemicon), raised against a recombinant full-length protein. There is a mosaic pattern of dystrophin expression, but the majority of fibers do not express dystrophin.